Multimonth Dispensing of Antiretroviral Therapy Protects the Most Vulnerable From 2 Pandemics at Once
- PMID: 32606089
- PMCID: PMC7326512
- DOI: 10.9745/GHSP-D-20-00160
Multimonth Dispensing of Antiretroviral Therapy Protects the Most Vulnerable From 2 Pandemics at Once
Abstract
We encourage governments in countries that have a high prevalence of people living with HIV to implement multimonth dispensing of antiretroviral therapy to safeguard both patients with HIV and health care workers from coronavirus disease COVID-19.
References
-
- Centers for Disease Control and Prevention. What to Know About HIV and COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/hiv.htm.... Updated March 18, 2020. Accessed March 31, 2020.
-
- U.S. Department of Health and Human Services. Interim Guidance for COVID-19 and Persons with HIV. https://aidsinfo.nih.gov/guidelines/html/8/covid-19-and-persons-with-hiv.... Updated April 21, 2020. Accessed March 31, 2020.
-
- U.S. President’s Emergency Plan for AIDS Relief. PEPFAR’s HIV Response in the Context of Coronavirus Disease 2019 (COVID-19). https://www.state.gov/pepfar/coronavirus/. Published March 25, 2020. Accessed April 9, 2020.
-
- Faturiyele IO, Appolinare T, Ngorima-Mabhena N, et al. Outcomes of community-based differentiated models of multi-month dispensing of antiretroviral medication among stable HIV-infected patients in Lesotho: a cluster randomised non-inferiority trial protocol. BMC Public Health. 2018;18(1):1069. 10.1186/s12889-018-5961-0. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical